Lendway, Inc. — Form 10-Q Summary
Filing identity: The request metadata names BLOOMIA HOLDINGS, INC. and 2022 Q3, but the supplied filing is Lendway, Inc.’s Form 10-Q for the quarter ended September 30, 2023. The summary below follows the filing.
Business context and reporting period
Lendway changed its name from Insignia Systems, Inc. and reincorporated in Delaware on August 4, 2023; its Nasdaq symbol changed to LDWY. On August 3, 2023, it sold certain assets and liabilities of its in-store marketing business and now presents that business as discontinued operations, restating prior periods. The company is developing a non-bank lending business, initially focused on collateralized loans primarily for agricultural purposes. The interim financial statements are unaudited.
Financial results and liquidity
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Continuing-operations revenue | None | None | None | None |
| Continuing-operations net loss | $1.511 million | $0.434 million | $2.654 million | $1.613 million |
| Net income, including discontinued operations and sale gain | $1.126 million | $11.801 million | $2.738 million | $10.779 million |
| Basic and diluted EPS | $0.63 | $6.58 | $1.53 | $6.02 |
Discontinued operations generated revenue of $1.976 million in Q3 2023 and $21.018 million in the first nine months of 2023. Gross profit was $0.408 million and $4.951 million, respectively. The filing does not provide a continuing-operations revenue base from which to calculate margins.
At September 30, 2023, cash and cash equivalents were $14.954 million, restricted cash was $0.085 million, working capital was $15.892 million, and shareholders’ equity was $15.902 million. Total assets were $17.638 million; the company reported no debt. Cash and restricted cash increased $0.515 million from year-end 2022.
For the first nine months, operating cash flow was negative $0.590 million overall, comprising $2.325 million used in continuing operations and $1.735 million provided by discontinued operations. Investing activities provided $1.533 million overall, including $1.581 million of reported sale proceeds from continuing operations. Financing activities used $0.428 million, including $0.437 million for share repurchases.
Material changes and unusual items
- Continuing-operations net losses increased year over year: 248.2% in Q3 and 64.5% for the nine-month period, mainly reflecting higher general and administrative expense.
- The 2023 sale produced a $3.044 million pretax gain and a $2.970 million after-tax gain. The stated $3.5 million sale price was subject to a $1.5 million post-closing adjustment; $0.2 million was placed in escrow for 12 months. The filing reports $1.581 million of sale proceeds in the cash-flow statement.
- Q3 2023 continuing-operation G&A included $0.926 million of severance and related benefits for former CEO Kristine Glancy; $0.650 million remained payable at quarter-end. The filing also reports separation benefits, retention awards, and employee bonuses associated with the transition.
- Prior-period net income benefited from a $12.0 million net litigation-settlement gain recorded in discontinued operations in Q3 2022. This is a major reason reported net income fell in 2023 despite the sale gain.
- The company repurchased 75,345 shares for approximately $0.437 million in Q3 under a program authorizing repurchases of up to 400,000 shares.
Outlook, commentary, and risks
Management anticipated minimal revenue and continuing-operations losses for the remainder of 2023. It said it was increasing lending-business marketing, meeting prospects, and working to reduce expenses. The company believed its cash would cover requirements for at least 12 months, but said future lending growth may require equity or debt financing and additional capital may not be available on acceptable terms. It is also evaluating strategic alternatives, with no assurance of a transaction.
Key disclosed risks include the lending business’s lack of operating history and revenue, borrower default and collateral risk, competition and changing funding costs, the need to build operational processes and controls, dependence on a small number of employees, and the availability of capital and strategic opportunities. Management reported disclosure controls were effective at September 30, 2023 and no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the issuer and reporting period: the supplied filing is Lendway, Inc., Q3 2023, not BLOOMIA HOLDINGS, INC. or Q3 2022.
- Review the final sale consideration, post-closing adjustment, escrow terms, and subsequent release or resolution of the escrow.
- Track lending-business launch progress, loan originations, credit performance, revenue generation, and required funding.
- Assess cash burn, remaining severance and other transition costs, and the basis for management’s 12-month liquidity assessment.
- Distinguish ongoing operating performance from discontinued operations, the sale gain, and the prior-year litigation-settlement gain when comparing earnings.